FDA Approves Teva’s Asthma Drug Cinqair as Add-on Treatment
Asthma, News
Teva Pharmaceutical Industries recently announced the approval of Cinqair (reslizumab) injection by the U.S. Food and Drug Administration (FDA) as an add-on maintenance treatment for patients with severe asthma, age 18 and ... Read more